Neuraxis (NRXS) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

NRXS Neuraxis

Watchlist

2.600
-0.330-11.26%

Close Sep 20 16:00 ET

17.79MMarket Cap-1165P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

NeurAxis to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024
GlobeNewswireSep 19 09:00 ET
Express News | NeurAxis Announces BlueCrossBlueShield Vermont Medical Policy Coverage For PENFS, Effective Oct. 1, 2024
BenzingaAug 13 09:05 ET
NeurAxis Announces BCBS of Vermont Medical Policy Coverage for PENFS, Effective October 1st 2024
Yahoo FinanceAug 13 09:00 ET
Earnings Call Summary | Neuraxis(NRXS.US) Q2 2024 Earnings Conference
moomoo AIAug 11 06:23 ET · Conference Call
NeurAxis, Inc. (NRXS) Q2 2024 Earnings Call Transcript
Earnings Call TranscriptsAug 11 05:44 ET
Neuraxis Shares Are Trading Higher After the Company Reported a Year-over-year Increase in Q2 EPS Results.
BenzingaAug 9 12:38 ET

Comments

Trytosaveabit

Jun 7 08:04

Watching for FDA response

$Neuraxis (NRXS.US)$ Neuraxis Announces New Submission to the FDA for the Expansion of Its Ib-Stim Label; Provides Compliance With NYSE Guidelines on Audit Disclosure

Trytosaveabit

May 16 08:19

If you don’t want to read the whole PR? Hehehe! This sums it up! Hehehe

$Neuraxis (NRXS.US)$ NeurAxis Announces Publication Of Medical Policy Coverage For Percutaneous Electrical Nerve Field Stimulation With A Blue Cross Blue Shield License In FL

Trytosaveabit

May 16 08:16

Update

$Neuraxis (NRXS.US)$ NeurAxis Announces New Medical Policy Coverage For Nearly Six Million Lives in Florida Globe Newswire 16-May-2024 9:00 AM CARMEL, Ind., May 16, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE:NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, today announced the publication of medical policy coverage for Percutaneous Electrical Nerve Field Stimu...

Moomoo AI

Jan 31 08:01

Timothy Henrichs' appointment could be a game-changer for NeurAxis' strategic commercialization activities. His arrival comes at a crucial growth phase, potentially impacting the company's financial performance and stock value.

Press Release: NeurAxis Appoints Timothy Henrichs as Chief Financial Officer

Moomoo AI

Nov 14, 2023 08:09

The secured funding is essential to accelerate the company's sales and marketing strategies. Additionally, increasing the policy coverage of IB-Stim(TM) and achieving clearance for RED serves as an opportunity to generate meaningful revenues from 2024 onwards.

Press Release: NeurAxis Secures $3 Million Financing

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

NRXS Neuraxis

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target